These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2676461)

  • 1. [Proteoglycans and osteoarthritis].
    Tammi M; Helminen H
    Duodecim; 1989; 105(15):1294-6. PubMed ID: 2676461
    [No Abstract]   [Full Text] [Related]  

  • 2. Cartilage proteoglycans in degenerative joint disease.
    Heinegård D; Inerot S; Olsson SE; Saxne T
    J Rheumatol; 1987 May; 14 Spec No():110-2. PubMed ID: 3625664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteoglycans from experimental osteoarthritic cartilage: degradation by neutral metalloproteases.
    Pelletier JP; Martel-Pelletier J; Malemud CJ
    J Rheumatol; 1987 May; 14 Spec No():113-5. PubMed ID: 3305933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine osteoarthritis: effects of endogenous neutral metalloproteoglycanases on articular cartilage proteoglycans.
    Pelletier JP; Martel-Pelletier J; Malemud CJ
    J Orthop Res; 1988; 6(3):379-88. PubMed ID: 3357086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cartilage aggrecan. Biosynthesis, degradation and osteoarthritis.
    Neame PJ; Sandy JD
    J Fla Med Assoc; 1994 Mar; 81(3):191-3. PubMed ID: 8195777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topographic variation in biglycan and decorin synthesis by articular cartilage in the early stages of osteoarthritis: an experimental study in sheep.
    Little CB; Ghosh P; Bellenger CR
    J Orthop Res; 1996 May; 14(3):433-44. PubMed ID: 8676257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of degradation of argecanes in osteoarthritic cartilage].
    Lohmander LS; Lark MW; Sandy JD
    Rev Prat; 1996 Mar; 46(6 Spec No):S11-S14. PubMed ID: 8731724
    [No Abstract]   [Full Text] [Related]  

  • 8. Demonstration of increased proteoglycan turnover in cartilage explants from dogs with experimental osteoarthritis.
    Carney SL; Billingham ME; Muir H; Sandy JD
    J Orthop Res; 1984; 2(3):201-6. PubMed ID: 6491812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proteoglycan in the pathogenesis of osteoarthrosis].
    Reumatizam; 1974; 21(5):187-90. PubMed ID: 4279433
    [No Abstract]   [Full Text] [Related]  

  • 10. Target tissue models: cartilage changes in experimental osteoarthritis in the dog.
    Adams ME
    J Rheumatol Suppl; 1983 Dec; 11():111-3. PubMed ID: 6583411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic processes in normal articular cartilage (age aspect) and in osteoarthrosis (literature review)].
    Zhadenov II; Pastel' VB
    Ortop Travmatol Protez; 1982 Mar; (3):65-70. PubMed ID: 7048191
    [No Abstract]   [Full Text] [Related]  

  • 12. Does oral glucosamine prevent the loss of proteoglycans in a rabbit model of osteoarthritis? Comment on the article by Tiraloche et al.
    Lammi M
    Arthritis Rheum; 2005 Nov; 52(11):3680; author reply 3680-81. PubMed ID: 16258912
    [No Abstract]   [Full Text] [Related]  

  • 13. Complexity of proteoglycan organization in articular cartilage: recent observations.
    Poole AR
    J Rheumatol Suppl; 1983 Dec; 11():70-5. PubMed ID: 6583420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of newly synthesised (35S)-proteoglycans and (35S)-proteoglycan turnover products of cartilage explant cultures from dogs with experimental osteoarthritis.
    Carney SL; Billingham ME; Muir H; Sandy JD
    J Orthop Res; 1985; 3(2):140-7. PubMed ID: 3998892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human articular cartilage proteoglycans are not undersulfated in osteoarthritis.
    Qu CJ; Rieppo J; Hyttinen MM; Lammi MJ; Kiviranta I; Kurkijärvi J; Jurvelin JS; Töyräs J
    Connect Tissue Res; 2007; 48(1):27-33. PubMed ID: 17364664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues.
    Monfort J; Pelletier JP; Garcia-Giralt N; Martel-Pelletier J
    Ann Rheum Dis; 2008 Jun; 67(6):735-40. PubMed ID: 17644553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A view on the pathogenesis of osteoarthritis.
    Howell DS; Woessner JF; Jimenez S; Seda H; Schumacher HR
    Bull Rheum Dis; 1978-1979; 29(8):996-1001. PubMed ID: 754840
    [No Abstract]   [Full Text] [Related]  

  • 18. Histological cartilage changes in a rabbit model of osteoarthritis.
    Vignon E; Bejui J; Mathieu P; Hartmann JD; Ville G; Evreux JC; Descotes J
    J Rheumatol; 1987 May; 14 Spec No():104-6. PubMed ID: 3625662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibronectin as a marker for osteoarthritis.
    Lust G; Burton-Wurster N; Leipold H
    J Rheumatol; 1987 May; 14 Spec No():28-9. PubMed ID: 3625673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
    Lohmander LS
    J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.